Novartis Home
At Novartis, we are reimagining medicine
At Novartis, we are reimagining medicine
Hardwiring the future
A Cell & Gene production unit staffed by a highly trained team at Novartis will soon begin operating in Stein, Switzerland.
Novartis Financial Results – Q2 2019
Novartis announced the company’s financial results for the second quarter and first half of 2019.
Novartis statement on Zolgensma
Novartis stands behind Zolgensma® for the treatment of children less than 2 years of age with spinal muscular atrophy.
Latest News
Novartis on Twitter